WuXi AppTec Co

WuXi AppTec Co Liabilities

The The Liabilities of WuXi AppTec Co (603259.SS) as of Nov 12, 2026 is 22.87 B CNY. In the previous year, The Liabilities was 21.24 B CNY — a change of 7.69% (higher).

Liabilities

22.87 BCNY

YoY

7.69%

Last updated:

In 2025, WuXi AppTec Co's total liabilities amounted to 22.87 B CNY, a 7.69% difference from the 21.24 B CNY total liabilities in the previous year.

The WuXi AppTec Co Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2018
4.82 B CNY
Jan 1, 2019
11.83 B CNY
Jan 1, 2020
13.57 B CNY
Jan 1, 2021
16.37 B CNY
Jan 1, 2022
17.76 B CNY
Jan 1, 2023
18.15 B CNY
Jan 1, 2024
21.24 B CNY
Jan 1, 2025
22.87 B CNY
The WuXi AppTec Co Liabilities history
YEARLiabilitiesYoY
22.87 BCNY+7.69%
21.24 BCNY+17.01%
18.15 BCNY+2.19%
17.76 BCNY+8.51%
16.37 BCNY+20.61%
13.57 BCNY+14.74%
11.83 BCNY+145.43%
4.82 BCNY-17.50%
5.84 BCNY+29.02%
4.53 BCNY+39.06%
3.26 BCNY+22.44%
2.66 BCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

WuXi AppTec Co Stock analysis

What does WuXi AppTec Co do? WuXi AppTec Co Ltd is a Chinese company that was founded in 2000 and specializes in the development of customer-oriented services in the pharmaceutical research and in vitro diagnostics sectors. The company operates multiple facilities in China, the USA, Europe, and Singapore. The business model of WuXi AppTec is based on the development and provision of services to meet the needs of customers worldwide. This includes activities such as bioanalysis, chemical development, drug manufacturing, and regulatory compliance and quality assurance services. In terms of various industries, the company is divided into three main divisions. The Chemical Division specializes in chemical development and drug manufacturing. The team has expertise in synthesizing complex molecules, scaling up for clinical trials, manufacturing bulk products for commercial use, and supplying APIs for formulation. The company has state-of-the-art facilities and technologies to ensure high product quality and fast production time. The Medical Device Division provides in vitro diagnostics for the global market to enable rapid and reliable medical diagnosis. The focus is on developing innovative technologies and applications in the fields of oncology, infectious diseases, and neurology. The company has many partnerships with leading in vitro diagnostics companies to enhance the quality and reach of products and services. The Biological Division specializes in the development of biopharmaceutical products and services. This includes the development of monoclonal antibodies to the production of recombinant proteins. The services include process development, manufacturing, characterization, and analysis of biological products. WuXi AppTec is at the forefront of technology and provides its customers with state-of-the-art facilities and technologies. In addition to the aforementioned services, WuXi AppTec also offers solutions in the field of bioanalytics, supporting the development of analytical methods and drug validation. The company has also recently expanded into other areas, including the acquisition of NextCODE Health, a firm specializing in genetic diagnostics and analysis tools. The company operates internationally and collaborates with a wide range of customers in the pharmaceutical and biotech sectors. It is also part of a global network of companies focusing on therapeutic technologies, clinical trials, drug marketing, and other aspects of the pharmaceutical industry. WuXi AppTec aims to provide its customers with high-quality products and services that are scientifically sound and effective. The company invests in research and development to provide its customers with the latest technologies and discoveries. WuXi AppTec Co is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing WuXi AppTec Co's Liabilities

WuXi AppTec Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating WuXi AppTec Co's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing WuXi AppTec Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

WuXi AppTec Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in WuXi AppTec Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about WuXi AppTec Co stock

The Liabilities of WuXi AppTec Co is 22.87 B CNY in 2025.

The Liabilities of WuXi AppTec Co changed from 21.24 B CNY to 22.87 B CNY, representing a 7.69% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities WuXi AppTec Co since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's WuXi AppTec Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — WuXi AppTec Co

All Key Metrics — WuXi AppTec Co